Published in Healthcare Mergers, Acquisitions and Ventures Week, February 17th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at BioVeris.
Report 1: BioVeris Corp. (BIOV) announced that it has entered into a Technology License Agreement with Baxter Healthcare Corp.
BioVeris received nonexclusive, worldwide patent rights and know-how to use Neisseria meningitidis group C vaccine as a component in new vaccine candidates for the prevention of meningitis and sepsis. The new combination vaccine candidates would consist of the Neisseria meningitidis group C components and additional vaccine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.